VIVJOA
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
74695-823 -
Package NDC
74695-823-18 -
Application number
NDA215888 -
SPL ID
47e259e7-fa6d-849f-e063-6294a90aeba7 -
SPL set ID
e21d5008-800e-4417-927f-14340341865f -
UNII
VHH774W97N -
RxCUI
2602582 -
RxCUI
2602588 -
RxCUI
2605802 -
RxCUI
2605803
What the source publishes
- Labeler
- Mycovia Pharmaceuticals, Inc.
- Active ingredients
- oteseconazole
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VIVJOA",
"splId": "47e259e7-fa6d-849f-e063-6294a90aeba7",
"labels": [
{
"setId": "e21d5008-800e-4417-927f-14340341865f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e21d5008-800e-4417-927f-14340341865f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e21d5008-800e-4417-927f-14340341865f"
}
],
"routes": [
"ORAL"
],
"labeler": "Mycovia Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 CONTAINER in 1 CARTON (74695-823-18) / 1 BLISTER PACK in 1 CONTAINER / 18 CAPSULE in 1 BLISTER PACK",
"package_ndc": "74695-823-18",
"identifierStatus": "well-formed",
"marketing_start_date": "20220711"
}
],
"productId": "74695-823_47e259e7-fa6d-849f-e063-6294a90aeba7",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "74695-823",
"deaSchedule": null,
"genericName": "oteseconazole",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "OTESECONAZOLE",
"strength": "150 mg/1"
}
],
"applicationNumber": "NDA215888",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220711",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175487",
"M0002083",
"N0000190113"
],
"unii": [
"VHH774W97N"
],
"rxcui": [
"2602582",
"2602588",
"2605802",
"2605803"
],
"spl_set_id": [
"e21d5008-800e-4417-927f-14340341865f"
],
"pharm_class_cs": [
"Azoles [CS]"
],
"pharm_class_epc": [
"Azole Antifungal [EPC]"
],
"pharm_class_moa": [
"Breast Cancer Resistance Protein Inhibitors [MoA]"
],
"manufacturer_name": [
"Mycovia Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:74695-823_47e259e7-fa6d-849f-e063-6294a90aeba7"